[Microbial translocation in HIV infection].
Contemporary antiretroviral therapy has significantly improved the prognosis of human immunodeficiency virus (HIV) infected individuals. However, treated individuals manifest increased mortality, compared to general population. This increased mortality seems to be associated with chronic immune activation which persist despite decrease of plasma HIV viremia levels. Recently, translocation of bacterial products from the gastrointestinal tract has been proposed as a major cause of pathological immune activation.